- Category: News
- Published: 31 August 2016
98 new synthetic cannabinoids came to surface and were registered in 2015. European monitoring agency for drugs and drug addiction (EMCDDA) sees no decline in the availability of new drugs on the internet market.
A growing number of NPS in Europe puts a significant pressure on the capacities of the forensic laboratories in the countries affected. Synthetic cannabinoids and opioids are also considered to be more toxic, having caused mass poisonings and deaths.
In addition to that, NPS – producers target a rather vulnerable sector of non-controlled synthetic opioids, fentanyls and suchlike, raising concerns on the medicines diverted from therapeutic providers and synthetic opioid products used for substitution treatment in some countries, according to the European Drug Report 2016.
ECAD is organizing the 3rd project conference Synthetic opioids and cannabinoids – a growing challenge for the region on Thursday, November 3. The conference will be angling Swedish specifics in the field of synthetic opioids. The plan is also to look closer at Latvian and Estonian drug markets in regards to synthetic opioids and to finalize our project findings.
Download the details in our Conference Announcement here (PDF).